The 2027 raise looks bigger than last year's, and many retirees will cheer. But one dollar figure hiding inside that announcement shows why the celebration may not last, and what seniors can do about…
The insurers that collect your premiums and annuity deposits also send checks back to shareholders every quarter. One of three giants yields nearly twice what another pays, and a Japan sales suspension complicates the…
A fairway view commands a serious premium in The Villages, but the hidden costs keep compounding long after closing day, and most buyers never stop to run the actual numbers before signing.
With Jensen Huang out as CEO and Washington asking whether NVIDIA truly knew its customers, one analyst puts a trillion-dollar price on the founder. Closed-door testimony and a board probe could decide what comes…
NVIDIA doubled its revenue while its stock fell toward a 52-week low, and even the pessimistic scenario in our model sits above today's price. What does the market fear that the numbers do not…
Most S&P 500 funds hand the biggest weights to the market's winners. One lesser-known fund flips that logic, loading up on unloved health insurers, automakers, and refiners. Does it deserve a spot in a…
One day after NVIDIA's CEO shake-up handed its rivals a windfall, the winners are giving it back fast. Analysts and a famed skeptic disagree on what comes next, and the answer may hinge on…
Retail traders keep pouring money into a leveraged Nvidia fund as it bleeds, and the math behind the losses is harsher than the 2x label suggests. With a CEO exit and earnings days away,…
Ondas posted blowout revenue growth and raised its guidance, yet the stock keeps sliding alongside its drone peers. What separates this sell-off from the fundamentals, and which headline could turn the group around?
Bitcoin slid below Strategy's cost basis just as ETF outflows mounted and an index giant prepared to cut the company loose. A single date at month's end could decide whether Saylor's bet gets relief…
A billionaire bond investor is sounding alarms about what he calls a hollow tree at the center of the stock market, and the numbers hiding beneath the S&P 500's record highs suggest his warning…
Microsoft keeps raising its dividend while pouring cash into AI data centers at a record pace. Can shareholder payouts survive a spending race that now rivals the company's free cash flow?
Pfizer's stock is rallying this year, yet investors who bought near the COVID peak are still underwater, even with every dividend reinvested. A looming 2027 patent test could decide whether that stake ever recovers.
A Fed field hearing on productivity puts a venture capitalist and a roster of tech executives on stage while rate hikes loom. Two stocks flinched, but the market's real tell sits in what the…
Boeing has a record $745 billion backlog and is still cutting about 2,500 airliner jobs, because its 737 factory can't reach 47 planes a month until 2027.